Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Dainippon Sumitomo Pharma

キッセイ薬品工業

小林製薬

Sekisui Chemical

ONO PHARMACEUTICAL

SAWAI PHARMACEUTICAL

TOAGOSEI CO

KANEKA

積水樹脂

Kao

Dr.Ci:Labo

KUMIAI CHEMICAL INDUSTRY

千寿製薬

Hitachi Chemical

栄研化学

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

PIONEER

メルコホールディングス

Hitachi Zosen etc.

日本アビオニクス

日本アビオニクス

Financial Statement Details: Dainippon Sumitomo Pharma (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: Dainippon Sumitomo Pharma (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 391 B  *  Net: ¥ 324 B  (Ratio: 82.93%)	[BS] 2010-03-31  *  Total: ¥ 626 B  *  Net: ¥ 343 B  (Ratio: 54.80%)	[BS] 2011-03-31  *  Total: ¥ 589 B  *  Net: ¥ 323 B  (Ratio: 54.92%)	[BS] 2012-03-31  *  Total: ¥ 559 B  *  Net: ¥ 319 B  (Ratio: 57.06%)	[BS] 2013-03-31  *  Total: ¥ 607 B  *  Net: ¥ 349 B  (Ratio: 57.52%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 21 B	¥ 13 B	¥ 14 B	¥ 12 B	¥ 18 B
Other Current Assets	¥ 241 B	¥ 273 B	¥ 318 B	¥ 321 B	¥ 314 B
Tangible Assets	¥ 69 B	¥ 74 B	¥ 69 B	¥ 66 B	¥ 69 B
Intangible Assets	¥ 6 B	¥ 199 B	¥ 143 B	¥ 107 B	¥ 146 B
Investment etc.	¥ 52 B	¥ 65 B	¥ 43 B	¥ 50 B	¥ 57 B
Total Assets	¥ 391 B	¥ 626 B	¥ 589 B	¥ 559 B	¥ 607 B
Current Liabilities	¥ 53 B	¥ 264 B	¥ 157 B	¥ 105 B	¥ 124 B
Fixed Liabilities	¥ 13 B	¥ 18 B	¥ 108 B	¥ 134 B	¥ 133 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Capital surplus etc.	¥ 302 B	¥ 321 B	¥ 301 B	¥ 296 B	¥ 326 B
Liabilities and net assets	¥ 391 B	¥ 626 B	¥ 589 B	¥ 559 B	¥ 607 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 264 B  *  Income: ¥ 19 B  (Ratio: 7.57%)	[PL] 2010-03-31  *  Sales: ¥ 296 B  *  Income: ¥ 20 B  (Ratio: 7.07%)	[PL] 2011-03-31  *  Sales: ¥ 379 B  *  Income: ¥ 16 B  (Ratio: 4.43%)	[PL] 2012-03-31  *  Sales: ¥ 350 B  *  Income: ¥ 8 B  (Ratio: 2.46%)	[PL] 2013-03-31  *  Sales: ¥ 347 B  *  Income: ¥ 10 B  (Ratio: 2.89%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 264 B	¥ 296 B	¥ 379 B	¥ 350 B	¥ 347 B
Cost of Sales	¥ 103 B	¥ 112 B	¥ 110 B	¥ 98 B	¥ 101 B
Gross profit	¥ 160 B	¥ 183 B	¥ 269 B	¥ 251 B	¥ 246 B
Other income	¥ 4 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
SG&A	¥ 129 B	¥ 148 B	¥ 238 B	¥ 231 B	¥ 220 B
Other expenses	¥ 15 B	¥ 16 B	¥ 17 B	¥ 15 B	¥ 18 B
Net income	¥ 19 B	¥ 20 B	¥ 16 B	¥ 8 B	¥ 10 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2009-03-31  *  OCF: ¥ 26 B  *  Cash: ¥ -6 B	[CF] 2010-03-31  *  OCF: ¥ 26 B  *  Cash: ¥ +7 B	[CF] 2011-03-31  *  OCF: ¥ 55 B  *  Cash: ¥ +24 B	[CF] 2012-03-31  *  OCF: ¥ 48 B  *  Cash: ¥ +9 B	[CF] 2013-03-31  *  OCF: ¥ 49 B  *  Cash: ¥ -20 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Operating CF	¥ 26 B	¥ 26 B	¥ 55 B	¥ 48 B	¥ 49 B
Investment CF	¥ -21 B	¥ -151 B	¥ -6 B	¥ -4 B	¥ -55 B
Financial CF	¥ -11 B	¥ 131 B	¥ -20 B	¥ -32 B	¥ -20 B
Foreign Exchange Effects	¥ 37 M	¥ 429 M	¥ -3 B	¥ -1 B	¥ 4 B
Net Change in Cash	¥ -6 B	¥ 7 B	¥ 24 B	¥ 9 B	¥ -20 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ 19 B  *  Net: ¥ +6 B	[SS] 2010-03-31  *  Income: ¥ 20 B  *  Net: ¥ +18 B	[SS] 2011-03-31  *  Income: ¥ 16 B  *  Net: ¥ -19 B	[SS] 2012-03-31  *  Income: ¥ 8 B  *  Net: ¥ -4 B	[SS] 2013-03-31  *  Income: ¥ 10 B  *  Net: ¥ +30 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 19 B	¥ 20 B	¥ 16 B	¥ 8 B	¥ 10 B
Purchase of treasury stock	¥ -92 M	¥ -3 M	¥ -2 M	¥ -1 M	¥ -1 M
Other Change in Stockholders Equity	¥ -1 M	¥ -734 M	¥ -280 M	-	-
Other Change in Net Assets	¥ -6 B	¥ 5 B	¥ -28 B	¥ -6 B	¥ 27 B
Net Change in Net Assets	¥ 6 B	¥ 18 B	¥ -19 B	¥ -4 B	¥ 30 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2009-03-31  *  Total: ¥ 387 B  *  Net: ¥ 323 B  (Ratio: 83.47%)	[BS] 2010-03-31  *  Total: ¥ 569 B  *  Net: ¥ 339 B  (Ratio: 59.64%)	[BS] 2011-03-31  *  Total: ¥ 561 B  *  Net: ¥ 349 B  (Ratio: 62.22%)	[BS] 2012-03-31  *  Total: ¥ 549 B  *  Net: ¥ 367 B  (Ratio: 66.80%)	[BS] 2013-03-31  *  Total: ¥ 554 B  *  Net: ¥ 376 B  (Ratio: 67.98%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash etc.	¥ 21 B	¥ 9 B	¥ 6 B	¥ 5 B	-
Other Current Assets	¥ 237 B	¥ 211 B	¥ 212 B	¥ 204 B	-
Tangible Assets	¥ 69 B	¥ 65 B	¥ 61 B	¥ 59 B	-
Intangible Assets	¥ 6 B	¥ 5 B	¥ 4 B	¥ 3 B	-
Investment etc.	¥ 53 B	¥ 277 B	¥ 276 B	¥ 277 B	¥ 554 B
Total Assets	¥ 387 B	¥ 569 B	¥ 561 B	¥ 549 B	¥ 554 B
Current Liabilities	¥ 50 B	¥ 216 B	¥ 106 B	¥ 50 B	¥ 177 B
Fixed Liabilities	¥ 13 B	¥ 13 B	¥ 105 B	¥ 131 B	-
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	-
Capital surplus etc.	¥ 300 B	¥ 317 B	¥ 327 B	¥ 344 B	¥ 376 B
Liabilities and net assets	¥ 387 B	¥ 569 B	¥ 561 B	¥ 549 B	¥ 554 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2009-03-31  *  Sales: ¥ 248 B  *  Income: ¥ 19 B  (Ratio: 7.94%)	[PL] 2010-03-31  *  Sales: ¥ 248 B  *  Income: ¥ 20 B  (Ratio: 8.42%)	[PL] 2011-03-31  *  Sales: ¥ 229 B  *  Income: ¥ 26 B  (Ratio: 11.65%)	[PL] 2012-03-31  *  Sales: ¥ 203 B  *  Income: ¥ 22 B  (Ratio: 10.84%)	[PL] 2013-03-31  *  Sales: ¥ 189 B  *  Income: ¥ 11 B  (Ratio: 5.98%)
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Sales	¥ 248 B	¥ 248 B	¥ 229 B	¥ 203 B	¥ 189 B
Cost of Sales	¥ 91 B	¥ 93 B	¥ 69 B	¥ 58 B	¥ 178 B
Gross profit	¥ 157 B	¥ 155 B	¥ 160 B	¥ 144 B	¥ 11 B
Other income	¥ 4 B	¥ 2 B	¥ 2 B	¥ 3 B	-
SG&A	¥ 126 B	¥ 119 B	¥ 116 B	¥ 108 B	-
Other expenses	¥ 14 B	¥ 16 B	¥ 19 B	¥ 17 B	-
Net income	¥ 19 B	¥ 20 B	¥ 26 B	¥ 22 B	¥ 11 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2009-03-31	2010-03-31	2011-03-31
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2009-03-31  *  Income: ¥ 19 B  *  Net: ¥ +6 B	[SS] 2010-03-31  *  Income: ¥ 20 B  *  Net: ¥ +16 B	[SS] 2011-03-31  *  Income: ¥ 26 B  *  Net: ¥ +9 B
Financial Statement Details	2009-03-31	2010-03-31	2011-03-31
Issuance of new shares	-	-	-
Dividends from surplus	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 19 B	¥ 20 B	¥ 26 B
Purchase of treasury stock	¥ -92 M	¥ -3 M	¥ -2 M
Other Change in Stockholders Equity	¥ -1 M	-	¥ -6 B
Other Change in Net Assets	¥ -6 B	¥ 2 B	¥ -2 B
Net Change in Net Assets	¥ 6 B	¥ 16 B	¥ 9 B

---

Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 318 B	¥ 324 B	¥ 343 B	¥ 323 B	¥ 319 B	¥ 349 B
Cash and deposits	¥ 28 B	¥ 21 B	¥ 13 B	¥ 14 B	¥ 12 B	¥ 18 B
Notes and accounts receivable-trade	¥ 86 B	¥ 79 B	¥ 93 B	¥ 107 B	¥ 101 B	¥ 97 B
Short-term investment securities	¥ 30 B	¥ 34 B	¥ 51 B	¥ 90 B	¥ 99 B	¥ 86 B
Merchandise and finished goods		¥ 39 B	¥ 46 B	¥ 38 B	¥ 42 B	¥ 45 B
Raw materials and supplies		¥ 11 B	¥ 15 B	¥ 15 B	¥ 13 B	¥ 13 B
Work in process		¥ 2 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 3 B
Deferred tax assets	¥ 13 B	¥ 17 B	¥ 32 B	¥ 33 B	¥ 31 B	¥ 30 B
Short-term loans receivable	¥ 40 B	¥ 50 B	¥ 25 B	¥ 25 B	¥ 25 B	¥ 34 B
Allowance for doubtful accounts	¥ -301 M	¥ -394 M	¥ -172 M	¥ -122 M	¥ -110 M	¥ -105 M
Other	¥ 4 B	¥ 6 B	¥ 6 B	¥ 4 B	¥ 5 B	¥ 3 B
Current assets	¥ 251 B	¥ 263 B	¥ 287 B	¥ 332 B	¥ 334 B	¥ 333 B
Buildings and structures	¥ 83 B	¥ 83 B	¥ 89 B	¥ 91 B	¥ 91 B	¥ 92 B
Accumulated depreciation and impairment loss	¥ -43 B	¥ -44 B	¥ -46 B	¥ -49 B	¥ -50 B	¥ -52 B
Buildings and structures, net	¥ 39 B	¥ 39 B	¥ 42 B	¥ 41 B	¥ 40 B	¥ 39 B
Machinery, equipment and vehicles	¥ 67 B	¥ 70 B	¥ 74 B	¥ 77 B	¥ 76 B	¥ 76 B
Accumulated depreciation and impairment loss	¥ -57 B	¥ -59 B	¥ -61 B	¥ -65 B	¥ -66 B	¥ -67 B
Machinery, equipment and vehicles, net	¥ 10 B	¥ 11 B	¥ 12 B	¥ 12 B	¥ 9 B	¥ 9 B
Land	¥ 9 B	¥ 9 B	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B
Construction in progress	¥ 6 B	¥ 4 B	¥ 2 B	¥ 941 M	¥ 2 B	¥ 5 B
Other	¥ 23 B	¥ 24 B	¥ 26 B	¥ 27 B	¥ 28 B	¥ 28 B
Accumulated depreciation and impairment loss	¥ -18 B	¥ -20 B	¥ -21 B	¥ -22 B	¥ -23 B	¥ -24 B
Other, net	¥ 4 B	¥ 4 B	¥ 5 B	¥ 4 B	¥ 4 B	¥ 4 B
Property, plant and equipment	¥ 70 B	¥ 69 B	¥ 74 B	¥ 69 B	¥ 66 B	¥ 69 B
Patent right			¥ 104 B	¥ 60 B	¥ 32 B	¥ 17 B
Goodwill			¥ 83 B	¥ 70 B	¥ 64 B	¥ 71 B
In-process research and development					¥ 5 B	¥ 50 B
Other		¥ 6 B	¥ 11 B	¥ 11 B	¥ 10 B	¥ 6 B
Intangible assets	¥ 5 B	¥ 6 B	¥ 199 B	¥ 143 B	¥ 107 B	¥ 146 B
Investment securities	¥ 44 B	¥ 33 B	¥ 53 B	¥ 27 B	¥ 29 B	¥ 40 B
Deferred tax assets	¥ 1 B	¥ 3 B	¥ 2 B	¥ 7 B	¥ 11 B	¥ 7 B
Other	¥ 26 B	¥ 14 B	¥ 10 B	¥ 8 B	¥ 9 B	¥ 9 B
Allowance for doubtful accounts	¥ -309 M	¥ -102 M	¥ -97 M	¥ -99 M	¥ -55 M	¥ -47 M
Investments and other assets	¥ 72 B	¥ 52 B	¥ 65 B	¥ 43 B	¥ 50 B	¥ 57 B
Noncurrent assets	¥ 148 B	¥ 127 B	¥ 339 B	¥ 256 B	¥ 225 B	¥ 273 B
Assets	¥ 399 B	¥ 391 B	¥ 626 B	¥ 589 B	¥ 559 B	¥ 607 B
Notes and accounts payable-trade	¥ 16 B	¥ 18 B	¥ 16 B	¥ 15 B	¥ 16 B	¥ 14 B
Provision for bonuses	¥ 8 B	¥ 8 B	¥ 7 B	¥ 7 B	¥ 7 B	¥ 7 B
Provision for sales rebates	¥ 458 M	¥ 412 M	¥ 15 B	¥ 15 B	¥ 18 B	¥ 19 B
Provision for sales returns	¥ 120 M	¥ 96 M	¥ 2 B	¥ 2 B	¥ 3 B	¥ 5 B
Accounts payable-other	¥ 22 B		¥ 33 B	¥ 33 B	¥ 30 B	¥ 34 B
Income taxes payable	¥ 10 B	¥ 6 B	¥ 8 B	¥ 7 B	¥ 5 B	¥ 2 B
Current portion of bonds					-	¥ 10 B
Current portion of long-term loans payable	¥ 4 B			¥ 10 B	¥ 10 B	¥ 10 B
Other	¥ 3 B	¥ 19 B	¥ 14 B	¥ 13 B	¥ 13 B	¥ 21 B
Current liabilities	¥ 67 B	¥ 53 B	¥ 264 B	¥ 157 B	¥ 105 B	¥ 124 B
Bonds payable				¥ 50 B	¥ 70 B	¥ 60 B
Long-term loans payable				¥ 43 B	¥ 48 B	¥ 35 B
Provision for retirement benefits	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B	¥ 10 B	¥ 11 B
Deferred tax liabilities					¥ 330 M	¥ 14 B
Other	¥ 4 B	¥ 4 B	¥ 8 B	¥ 5 B	¥ 5 B	¥ 12 B
Noncurrent liabilities	¥ 13 B	¥ 13 B	¥ 18 B	¥ 108 B	¥ 134 B	¥ 133 B
Liabilities	¥ 81 B	¥ 66 B	¥ 283 B	¥ 265 B	¥ 240 B	¥ 257 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Capital surplus	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B
Retained earnings	¥ 268 B	¥ 281 B	¥ 294 B	¥ 304 B	¥ 305 B	¥ 308 B
Treasury stock	¥ -557 M	¥ -643 M	¥ -646 M	¥ -648 M	¥ -649 M	¥ -651 M
Shareholders' equity	¥ 306 B	¥ 319 B	¥ 332 B	¥ 341 B	¥ 343 B	¥ 346 B
Valuation difference on available-for-sale securities	¥ 11 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 8 B	¥ 14 B
Foreign currency translation adjustment			¥ 3 B	¥ -23 B	¥ -32 B	¥ -11 B
Valuation and translation adjustments	¥ 11 B	¥ 5 B	¥ 11 B	¥ -17 B	¥ -24 B	¥ 3 B
Liabilities and net assets	¥ 399 B	¥ 391 B	¥ 626 B	¥ 589 B	¥ 559 B	¥ 607 B
Short-term loans payable			¥ 165 B	¥ 50 B	-
Provision for directors' retirement benefits	¥ 34 M	¥ 42 M	¥ 50 M	¥ 6 M
Minority interests	¥ 83 M	¥ 87 M
Inventories	¥ 48 B
Provision for loss on litigation	¥ 1 B
Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 263 B	¥ 264 B	¥ 296 B	¥ 379 B	¥ 350 B	¥ 347 B
Operating income	¥ 39 B	¥ 31 B	¥ 35 B	¥ 30 B	¥ 20 B	¥ 25 B
Ordinary income	¥ 37 B	¥ 31 B	¥ 33 B	¥ 28 B	¥ 18 B	¥ 24 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 16 B	¥ 8 B	¥ 10 B
Comprehensive income				¥ -12 B	¥ 2 B	¥ 37 B
Cost of sales	¥ 99 B	¥ 103 B	¥ 112 B	¥ 110 B	¥ 98 B	¥ 101 B
Salaries	¥ 16 B	¥ 16 B	¥ 20 B	¥ 34 B	¥ 36 B	¥ 34 B
Depreciation				¥ 31 B	¥ 27 B	¥ 25 B
Provision for bonuses	¥ 5 B	¥ 5 B	¥ 4 B	¥ 4 B	¥ 5 B	¥ 5 B
Research and development expenses	¥ 47 B	¥ 52 B	¥ 51 B	¥ 68 B	¥ 56 B	¥ 59 B
Other	¥ 55 B	¥ 54 B	¥ 71 B	¥ 99 B	¥ 105 B	¥ 95 B
Selling, general and administrative expenses	¥ 124 B	¥ 129 B	¥ 148 B	¥ 238 B	¥ 231 B	¥ 220 B
Gross profit	¥ 164 B	¥ 160 B	¥ 183 B	¥ 269 B	¥ 251 B	¥ 246 B
Gross profit-net	¥ 164 B	¥ 160 B	¥ 183 B	¥ 269 B	¥ 251 B	¥ 246 B
Provision for sales returns				-	¥ 11 M	-
Reversal of provision for sales returns	¥ 1 M	¥ 23 M	¥ 34 M	¥ 16 M	-	¥ 8 M
Interest income	¥ 853 M	¥ 974 M	¥ 635 M	¥ 494 M	¥ 347 M	¥ 330 M
Dividends income	¥ 675 M	¥ 736 M	¥ 592 M	¥ 753 M	¥ 676 M	¥ 760 M
Foreign exchange gains					¥ 102 M	¥ 734 M
Real estate rent			¥ 226 M		¥ 219 M	¥ 193 M
Other	¥ 1 B	¥ 1 B	¥ 563 M	¥ 1 B	¥ 842 M	¥ 1 B
Non-operating income	¥ 3 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 3 B
Interest expenses	¥ 127 M	¥ 93 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Contribution	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Other	¥ 1 B	¥ 364 M	¥ 782 M	¥ 1 B	¥ 903 M	¥ 622 M
Non-operating expenses	¥ 5 B	¥ 2 B	¥ 4 B	¥ 5 B	¥ 3 B	¥ 3 B
Gain on sales of noncurrent assets				-	¥ 1 B	-
Extraordinary income	¥ 3 B	¥ 1 B		-	¥ 1 B	-
Impairment loss				¥ 3 B	¥ 2 B	¥ 416 M
Loss on valuation of investment securities		¥ 281 M	¥ 843 M	¥ 320 M	¥ 223 M	-
Business structure improvement expenses				-	¥ 1 B	¥ 4 B
Loss on litigation					-	¥ 1 B
Extraordinary loss		¥ 281 M	¥ 2 B	¥ 3 B	¥ 3 B	¥ 6 B
Income before income taxes	¥ 41 B	¥ 32 B	¥ 31 B	¥ 25 B	¥ 16 B	¥ 18 B
Income taxes	¥ 15 B	¥ 12 B	¥ 10 B	¥ 8 B	¥ 7 B	¥ 8 B
Income taxes-current	¥ 18 B	¥ 14 B	¥ 13 B	¥ 13 B	¥ 12 B	¥ 6 B
Income taxes-deferred	¥ -2 B	¥ -1 B	¥ -3 B	¥ -5 B	¥ -4 B	¥ 1 B
Income before minority interests				¥ 16 B	¥ 8 B	¥ 10 B
Valuation difference on available-for-sale securities				¥ -2 B	¥ 2 B	¥ 6 B
Foreign currency translation adjustment				¥ -26 B	¥ -8 B	¥ 21 B
Other comprehensive income				¥ -28 B	¥ -6 B	¥ 27 B
Comprehensive income attributable to owners of the parent				¥ -12 B	¥ 2 B	¥ 37 B
Comprehensive income attributable to minority interests					-	-
Provision of allowance for doubtful accounts	¥ 76 M	¥ 95 M	¥ 14 M
Provision for directors' retirement benefits	¥ 10 M	¥ 10 M	¥ 12 M	¥ 3 M
Equity in earnings of affiliates				¥ 443 M
Insurance income				¥ 399 M
Reversal of allowance for doubtful accounts			¥ 234 M
Loss on retirement of noncurrent assets		¥ 446 M	¥ 472 M
Minority interests in income	¥ 75 M	¥ 11 M	¥ 6 M
Reversal of provision for loss on litigation		¥ 1 B
Loss on valuation of inventories	¥ 1 B
Loss on abandonment of inventories	¥ 978 M
Gain on sales of investment securities	¥ 3 B
Consolidated :Cash flow statement (CF) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Cash flow statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Subtotal	¥ 46 B	¥ 43 B	¥ 37 B	¥ 70 B	¥ 62 B	¥ 63 B
Depreciation and amortization	¥ 11 B	¥ 11 B	¥ 17 B	¥ 40 B	¥ 36 B	¥ 31 B
Impairment loss				¥ 3 B	¥ 2 B	¥ 416 M
Amortization of goodwill			¥ 866 M	¥ 4 B	¥ 3 B	¥ 3 B
Interest and dividends income	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Interest expenses	¥ 127 M	¥ 93 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Loss (gain) on sales of property, plant and equipment				-	¥ -1 B	-
Decrease (increase) in notes and accounts receivable-trade	¥ 2 B	¥ 6 B	¥ 1 B	¥ -15 B	¥ 4 B	¥ 7 B
Decrease (increase) in inventories	¥ -2 B	¥ -5 B	¥ 2 B	¥ 8 B	¥ -2 B	¥ -3 B
Increase (decrease) in notes and accounts payable-trade	¥ -732 M	¥ 2 B	¥ -1 B	¥ -1 B	¥ 1 B	¥ -2 B
Increase (decrease) in provision for retirement benefits	¥ -1 B	¥ 323 M	¥ 1 B	¥ 368 M	¥ -129 M	¥ -228 M
Increase (decrease) in other provision	¥ 93 M	¥ -269 M	¥ -2 B	¥ 2 B	¥ 5 B	¥ 128 M
Loss (gain) on valuation of investment securities		¥ 281 M	¥ 843 M	¥ 320 M	¥ 223 M	-
Business structure improvement expenses				-	¥ 1 B	¥ 4 B
Loss on litigation					-	¥ 1 B
Increase (decrease) in accounts payable-other			¥ -13 B	¥ 2 B	¥ -3 B	¥ -1 B
Other, net	¥ 284 M	¥ -843 M	¥ -1 B	¥ -703 M	¥ -1 B	¥ 5 B
Interest and dividends income received	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Interest expenses paid	¥ -64 M	¥ -69 M	¥ -921 M	¥ -1 B	¥ -1 B	¥ -1 B
Income taxes paid	¥ -15 B	¥ -18 B	¥ -11 B	¥ -14 B	¥ -14 B	¥ -10 B
Net cash provided by (used in) operating activities	¥ 32 B	¥ 26 B	¥ 26 B	¥ 55 B	¥ 48 B	¥ 49 B
Purchase of short-term investment securities		¥ -1 B	¥ -757 M	¥ -11 B	¥ -35 B	¥ -45 B
Proceeds from sales of short-term investment securities	¥ 2 B	¥ 2 B	¥ 19 B	¥ 647 M	¥ 6 B	¥ 166 M
Purchase of property, plant and equipment	¥ -7 B	¥ -13 B	¥ -5 B	¥ -7 B	¥ -6 B	¥ -7 B
Proceeds from sales of property, plant and equipment				¥ 52 M	¥ 1 B	¥ 18 M
Purchase of investment securities	¥ -6 B	¥ -3 B	¥ -1 B	¥ -2 B	¥ -3 B	¥ -2 B
Proceeds from sales of investment securities	¥ 3 B			¥ 3 B	¥ 362 M	¥ 2 M
Payments of loans receivable					-	¥ -7 B
Proceeds from redemption of securities			¥ 6 B	¥ 10 B	¥ 34 B	¥ 39 B
Proceeds from redemption of investment securities	¥ 1 B		¥ 2 B	¥ 1 B	¥ 46 M	¥ 264 M
Purchase of intangible assets	¥ -2 B	¥ -3 B	¥ -889 M	¥ -2 B	¥ -2 B	¥ -2 B
Payments into time deposits	¥ -6 B	¥ -1 B			-	¥ -8 B
Proceeds from withdrawal of time deposits	¥ 5 B	¥ 12 B	¥ 5 B		-	¥ 2 B
Purchase of investments in subsidiaries resulting in change in scope of consolidation			¥ -200 B		-	¥ -24 B
Other, net	¥ 84 M	¥ 38 M	¥ -790 M	¥ -485 M	¥ -20 M	¥ 2 M
Net cash provided by (used in) investing activities	¥ -50 B	¥ -21 B	¥ -151 B	¥ -6 B	¥ -4 B	¥ -55 B
Proceeds from long-term loans payable				¥ 58 B	¥ 15 B	-
Repayment of long-term loans payable		¥ -4 B		¥ -5 B	¥ -10 B	¥ -13 B
Proceeds from issuance of bonds				¥ 49 B	¥ 19 B	-
Cash dividends paid	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net increase (decrease) in short-term loans payable	¥ -500 M		¥ 164 B	¥ -115 B	¥ -50 B	-
Net decrease (increase) in treasury stock	¥ -82 M	¥ -92 M	¥ -3 M	¥ -1 M	¥ -1 M	¥ -1 M
Other, net			¥ -21 M	¥ -73 M	¥ -67 M	¥ -68 M
Net cash provided by (used in) financing activities	¥ -6 B	¥ -11 B	¥ 131 B	¥ -20 B	¥ -32 B	¥ -20 B
Effect of exchange rate change on cash and cash equivalents	¥ -140 M	¥ 37 M	¥ 429 M	¥ -3 B	¥ -1 B	¥ 4 B
Net increase (decrease) in cash and cash equivalents	¥ -25 B	¥ -6 B	¥ 7 B	¥ 24 B	¥ 9 B	¥ -20 B
Cash and cash equivalents	¥ 56 B	¥ 49 B	¥ 58 B	¥ 82 B	¥ 92 B	¥ 71 B
Proceeds from sales of intangible assets				¥ 1 B	-
Redemption of bonds			¥ -25 B	¥ -74 M	-
Increase (decrease) in cash and cash equivalents resulting from change of scope of consolidation	¥ 70 M		¥ 1 B	¥ 386 M	-
Loss on retirement of property, plant and equipment		¥ 256 M	¥ 230 M	¥ 266 M
Net decrease (increase) in short-term loans receivable	¥ -40 B	¥ -10 B	¥ 25 B
Cash dividends paid to minority shareholders	¥ -7 M	-	-
Loss (gain) on sales of investment securities	¥ -3 B
Purchase of investments in subsidiaries	¥ -839 M
Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Total changes of items during the period					-	-
Total changes of items during the period	-				-	-
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Disposal of treasury stock	¥ -4 M	¥ -6 M	-	-	-	-
Total changes of items during the period	¥ 19 B	¥ 12 B	¥ 13 B	¥ 9 B	¥ 1 B	¥ 2 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M	¥ -1 M
Disposal of treasury stock	¥ 25 M	¥ 22 M			-	-
Total changes of items during the period	¥ -77 M	¥ -85 M	¥ -3 M	¥ -1 M	¥ -1 M	¥ -1 M
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 16 B	¥ 8 B	¥ 10 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M	¥ -1 M
Disposal of treasury stock	¥ 20 M	¥ 16 M			-	-
Total changes of items during the period	¥ 19 B	¥ 12 B	¥ 13 B	¥ 9 B	¥ 1 B	¥ 2 B
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B	¥ 6 B
Total changes of items during the period	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B	¥ 6 B
Net changes of items other than shareholders' equity			¥ 3 B	¥ -26 B	¥ -8 B	¥ 21 B
Total changes of items during the period			¥ 3 B	¥ -26 B	¥ -8 B	¥ 21 B
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 6 B	¥ -28 B	¥ -6 B	¥ 27 B
Total changes of items during the period	¥ -6 B	¥ -6 B	¥ 6 B	¥ -28 B	¥ -6 B	¥ 27 B
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 16 B	¥ 8 B	¥ 10 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M	¥ -1 M
Disposal of treasury stock	¥ 20 M	¥ 16 M			-	-
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 5 B	¥ -28 B	¥ -6 B	¥ 27 B
Total changes of items during the period	¥ 12 B	¥ 6 B	¥ 18 B	¥ -19 B	¥ -4 B	¥ 30 B
Change of scope of consolidation	¥ 90 M		¥ -733 M	¥ -159 M	-
Change of scope of consolidation	¥ 90 M		¥ -733 M	¥ -159 M	-
Change of scope of consolidation	¥ 90 M		¥ -733 M	¥ -280 M	-
Net changes of items other than shareholders' equity	¥ -838 M	¥ 4 M	¥ -87 M
Total changes of items during the period	¥ -838 M	¥ 4 M	¥ -87 M
Disposal of treasury stock	-

Non-Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Balance sheet (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net assets	¥ 317 B	¥ 323 B	¥ 339 B	¥ 349 B	¥ 367 B
Cash and deposits	¥ 27 B	¥ 21 B	¥ 9 B	¥ 6 B	¥ 5 B
Notes receivable-trade	¥ 1 B	¥ 1 B	¥ 983 M	¥ 370 M	¥ 257 M
Accounts receivable-trade	¥ 80 B	¥ 74 B	¥ 75 B	¥ 79 B	¥ 66 B
Short-term investment securities	¥ 30 B	¥ 34 B	¥ 30 B	¥ 40 B	¥ 42 B
Merchandise and finished goods		¥ 38 B	¥ 37 B	¥ 30 B	¥ 34 B
Raw materials and supplies		¥ 11 B	¥ 12 B	¥ 11 B	¥ 11 B
Work in process	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 2 B
Advance payments-trade	¥ 1 B	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B
Prepaid expenses	¥ 351 M	¥ 107 M	¥ 110 M	¥ 26 M	¥ 18 M
Deferred tax assets	¥ 13 B	¥ 17 B	¥ 20 B	¥ 18 B	¥ 16 B
Short-term loans receivable from subsidiaries and affiliates	¥ 41 B	¥ 51 B	¥ 25 B	¥ 25 B	¥ 25 B
Allowance for doubtful accounts	¥ -239 M	¥ -340 M	¥ -106 M	¥ -108 M	¥ -96 M
Other	¥ 2 B	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B
Current assets	¥ 245 B	¥ 258 B	¥ 221 B	¥ 218 B	¥ 209 B
Buildings	¥ 78 B	¥ 78 B	¥ 79 B	¥ 81 B	¥ 81 B
Accumulated depreciation and impairment loss	¥ -39 B	¥ -40 B	¥ -42 B	¥ -45 B	¥ -45 B
Buildings, net	¥ 38 B	¥ 38 B	¥ 37 B	¥ 36 B	¥ 35 B
Structures	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Accumulated depreciation and impairment loss	¥ -3 B	¥ -3 B	¥ -3 B	¥ -4 B	¥ -4 B
Structures, net	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 943 M
Machinery and equipment	¥ 67 B	¥ 70 B	¥ 71 B	¥ 74 B	¥ 74 B
Accumulated depreciation and impairment loss	¥ -57 B	¥ -59 B	¥ -60 B	¥ -63 B	¥ -65 B
Machinery and equipment, net	¥ 10 B	¥ 11 B	¥ 11 B	¥ 10 B	¥ 8 B
Vehicles	¥ 370 M	¥ 354 M	¥ 354 M	¥ 345 M	¥ 345 M
Accumulated depreciation and impairment loss	¥ -330 M	¥ -318 M	¥ -326 M	¥ -325 M	¥ -327 M
Vehicles, net	¥ 40 M	¥ 36 M	¥ 28 M	¥ 19 M	¥ 18 M
Tools, furniture and fixtures	¥ 22 B	¥ 24 B	¥ 24 B	¥ 24 B	¥ 25 B
Accumulated depreciation and impairment loss	¥ -18 B	¥ -19 B	¥ -20 B	¥ -21 B	¥ -21 B
Tools, furniture and fixtures, net	¥ 4 B	¥ 4 B	¥ 3 B	¥ 3 B	¥ 3 B
Land	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B	¥ 9 B
Construction in progress	¥ 6 B	¥ 4 B	¥ 2 B	¥ 913 M	¥ 1 B
Property, plant and equipment	¥ 70 B	¥ 69 B	¥ 65 B	¥ 61 B	¥ 59 B
Patent right	¥ 6 M	¥ 4 M	¥ 2 M	¥ 1 M	-
Right of trademark	¥ 236 M	¥ 163 M	¥ 90 M	¥ 20 M	¥ 13 M
Software	¥ 4 B	¥ 5 B	¥ 4 B	¥ 2 B	¥ 2 B
Other	¥ 115 M	¥ 105 M	¥ 104 M	¥ 799 M	¥ 635 M
Intangible assets	¥ 5 B	¥ 6 B	¥ 5 B	¥ 4 B	¥ 3 B
Investment securities	¥ 43 B	¥ 32 B	¥ 33 B	¥ 25 B	¥ 28 B
Stocks of subsidiaries and affiliates	¥ 2 B	¥ 2 B	¥ 231 B	¥ 236 B	¥ 236 B
Investments in capital	¥ 1 M	¥ 1 M	¥ 1 M		-
Investments in capital of subsidiaries and affiliates	¥ 1 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Long-term loans receivable	¥ 5 M	¥ 4 M	¥ 4 M	¥ 4 M	¥ 3 M
Long-term loans receivable from employees	¥ 31 M	¥ 8 M	¥ 3 M	¥ 2 M	¥ 1 M
Long-term prepaid expenses	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 3 B
Deferred tax assets	¥ 1 B	¥ 3 B	¥ 1 B	¥ 2 B	¥ 523 M
Other	¥ 6 B	¥ 8 B	¥ 4 B	¥ 4 B	¥ 5 B
Allowance for doubtful accounts	¥ -254 M	¥ -90 M	¥ -89 M	¥ -94 M	¥ -51 M
Investments and other assets	¥ 73 B	¥ 53 B	¥ 277 B	¥ 276 B	¥ 277 B
Noncurrent assets	¥ 149 B	¥ 128 B	¥ 348 B	¥ 343 B	¥ 339 B
Assets	¥ 394 B	¥ 387 B	¥ 569 B	¥ 561 B	¥ 549 B
Accounts payable-trade	¥ 14 B	¥ 17 B	¥ 14 B	¥ 7 B	¥ 9 B
Accrued expenses	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Advances received				¥ 1 B	¥ 927 M
Provision for bonuses	¥ 8 B	¥ 7 B	¥ 7 B	¥ 6 B	¥ 6 B
Provision for sales rebates	¥ 458 M	¥ 412 M	¥ 377 M	¥ 511 M	¥ 441 M
Provision for sales returns	¥ 120 M	¥ 96 M	¥ 61 M	¥ 43 M	¥ 55 M
Accounts payable-other	¥ 22 B	¥ 16 B	¥ 18 B	¥ 20 B	¥ 16 B
Income taxes payable	¥ 10 B	¥ 6 B	¥ 8 B	¥ 6 B	¥ 4 B
Accrued consumption taxes	¥ 551 M	¥ 368 M	¥ 1 B	¥ 407 M	-
Deposits received	¥ 302 M	¥ 300 M	¥ 351 M	¥ 346 M	¥ 324 M
Short-term loans payable			¥ 165 B	¥ 50 B	-
Current portion of long-term loans payable	¥ 4 B			¥ 10 B	¥ 10 B
Current liabilities	¥ 64 B	¥ 50 B	¥ 216 B	¥ 106 B	¥ 50 B
Bonds payable				¥ 50 B	¥ 70 B
Long-term loans payable				¥ 43 B	¥ 48 B
Provision for retirement benefits	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B	¥ 10 B
Long-term deposits received	¥ 3 B	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B
Long-term accounts payable-other	¥ 1 B	¥ 926 M	¥ 398 M	¥ 19 M	¥ 120 M
Noncurrent liabilities	¥ 13 B	¥ 13 B	¥ 13 B	¥ 105 B	¥ 131 B
Liabilities	¥ 77 B	¥ 63 B	¥ 229 B	¥ 212 B	¥ 182 B
Capital stock	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B	¥ 22 B
Legal capital surplus	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B
Capital surplus	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B	¥ 15 B
Legal retained earnings	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B	¥ 5 B
Reserve for advanced depreciation of noncurrent assets	¥ 1 B	¥ 1 B	¥ 968 M	¥ 923 M	¥ 1 B
General reserve	¥ 233 B	¥ 250 B	¥ 262 B	¥ 275 B	¥ 275 B
Retained earnings brought forward	¥ 27 B	¥ 23 B	¥ 25 B	¥ 24 B	¥ 39 B
Other retained earnings	¥ 262 B	¥ 274 B	¥ 288 B	¥ 301 B	¥ 316 B
Retained earnings	¥ 267 B	¥ 280 B	¥ 294 B	¥ 306 B	¥ 321 B
Treasury stock	¥ -557 M	¥ -643 M	¥ -646 M	¥ -648 M	¥ -649 M
Shareholders' equity	¥ 305 B	¥ 317 B	¥ 331 B	¥ 344 B	¥ 359 B
Valuation difference on available-for-sale securities	¥ 11 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 7 B
Valuation and translation adjustments	¥ 11 B	¥ 5 B	¥ 7 B	¥ 5 B	¥ 7 B
Liabilities and net assets	¥ 394 B	¥ 387 B	¥ 569 B	¥ 561 B	¥ 549 B
Reserve for special depreciation	¥ 58 M	¥ 21 M
Goodwill	¥ 14 M	¥ 2 M
Merchandise	¥ 3 B
Finished goods	¥ 12 B
Semi-finished goods	¥ 18 B
Raw materials	¥ 7 B
Supplies	¥ 1 B
Long-term time deposits	¥ 16 B
Provision for loss on litigation	¥ 1 B
Other capital surplus
Non-Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Income statement (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net sales	¥ 247 B	¥ 248 B	¥ 248 B	¥ 229 B	¥ 203 B
Operating income	¥ 39 B	¥ 30 B	¥ 35 B	¥ 43 B	¥ 36 B
Ordinary income	¥ 38 B	¥ 30 B	¥ 34 B	¥ 41 B	¥ 35 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 26 B	¥ 22 B
Net sales of goods	¥ 50 B	¥ 52 B	¥ 55 B	¥ 22 B	¥ 10 B
Net sales of finished goods	¥ 197 B	¥ 195 B	¥ 192 B	¥ 207 B	¥ 193 B
Cost of sales	¥ 86 B	¥ 91 B	¥ 93 B	¥ 69 B	¥ 58 B
Cost of purchased goods	¥ 41 B	¥ 43 B	¥ 44 B	¥ 14 B	¥ 4 B
Cost of products manufactured	¥ 49 B	¥ 53 B	¥ 51 B	¥ 52 B	¥ 58 B
Transfer to other account	¥ 3 B	¥ 3 B	¥ 2 B	¥ 4 B	¥ 247 M
Beginning merchandise and finished goods	¥ 15 B	¥ 34 B	¥ 38 B	¥ 37 B	¥ 30 B
Total		¥ 132 B	¥ 134 B	¥ 104 B	¥ 93 B
Ending merchandise and finished goods	¥ 16 B	¥ 38 B	¥ 37 B	¥ 30 B	¥ 34 B
Salaries	¥ 15 B	¥ 15 B	¥ 16 B	¥ 15 B	¥ 15 B
Depreciation	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Provision for bonuses	¥ 5 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Research and development expenses	¥ 47 B	¥ 52 B	¥ 48 B	¥ 49 B	¥ 40 B
Promotion expenses	¥ 9 B	¥ 10 B	¥ 10 B	¥ 9 B	¥ 9 B
Other	¥ 42 B	¥ 39 B	¥ 37 B	¥ 35 B	¥ 34 B
Selling, general and administrative expenses	¥ 122 B	¥ 126 B	¥ 119 B	¥ 116 B	¥ 108 B
Gross profit	¥ 161 B	¥ 157 B	¥ 155 B	¥ 160 B	¥ 144 B
Gross profit-net	¥ 161 B	¥ 157 B	¥ 155 B	¥ 160 B	¥ 144 B
Provision for sales returns				-	¥ 11 M
Reversal of provision for sales returns	¥ 1 M	¥ 23 M	¥ 34 M	¥ 17 M	-
Interest income	¥ 509 M	¥ 673 M	¥ 326 M	¥ 111 M	¥ 169 M
Dividends income	¥ 678 M	¥ 745 M	¥ 602 M	¥ 758 M	¥ 1 B
Real estate rent			¥ 291 M	¥ 355 M	¥ 346 M
Insurance income				¥ 399 M	¥ 8 M
Miscellaneous income	¥ 1 B	¥ 1 B	¥ 551 M	¥ 801 M	¥ 530 M
Non-operating income	¥ 3 B	¥ 3 B	¥ 2 B	¥ 2 B	¥ 2 B
Interest expenses	¥ 116 M	¥ 83 M	¥ 803 M	¥ 1 B	¥ 596 M
Interest on bonds				¥ 24 M	¥ 474 M
Contribution	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Miscellaneous loss	¥ 1 B	¥ 374 M	¥ 459 M	¥ 1 B	¥ 757 M
Non-operating expenses	¥ 4 B	¥ 2 B	¥ 3 B	¥ 4 B	¥ 3 B
Gain on sales of noncurrent assets				-	¥ 1 B
Extraordinary income	¥ 3 B	¥ 1 B		-	¥ 1 B
Impairment loss				¥ 1 B	-
Loss on valuation of investment securities		¥ 278 M	¥ 843 M	¥ 157 M	¥ 223 M
Extraordinary loss	¥ 782 M	¥ 278 M	¥ 2 B	¥ 1 B	¥ 223 M
Income before income taxes	¥ 41 B	¥ 31 B	¥ 32 B	¥ 39 B	¥ 36 B
Income taxes	¥ 15 B	¥ 11 B	¥ 11 B	¥ 13 B	¥ 14 B
Income taxes-current	¥ 18 B	¥ 13 B	¥ 13 B	¥ 11 B	¥ 10 B
Income taxes-deferred	¥ -2 B	¥ -1 B	¥ -2 B	¥ 1 B	¥ 3 B
Provision of allowance for doubtful accounts	¥ 79 M	¥ 98 M		¥ 2 M
Interest on securities	¥ 369 M	¥ 319 M	¥ 225 M
Reversal of allowance for doubtful accounts			¥ 234 M
Loss on retirement of noncurrent assets		¥ 444 M	¥ 470 M
Reversal of provision for loss on litigation		¥ 1 B
Loss on abandonment of inventories	¥ 971 M
Gain on sales of investment securities	¥ 3 B
Loss on valuation of stocks of subsidiaries and affiliates	¥ 782 M
Non-Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Shareowners' equity (Annual )	2008-03-31	2009-03-31	2010-03-31	2011-03-31	2012-03-31
Total changes of items during the period					-
Total changes of items during the period					-
Total changes of items during the period	¥ -1 M				-
Total changes of items during the period					-
Provision of reserve for advanced depreciation of noncurrent assets				-	¥ 702 M
Reversal of reserve for advanced depreciation of noncurrent assets		¥ -45 M	¥ -45 M	¥ -45 M	¥ -45 M
Total changes of items during the period	¥ -45 M	¥ -45 M	¥ -45 M	¥ -45 M	¥ 657 M
Provision of general reserve	¥ 17 B	¥ 17 B	¥ 12 B	¥ 13 B	-
Total changes of items during the period	¥ 17 B	¥ 17 B	¥ 12 B	¥ 13 B	-
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Disposal of treasury stock	¥ -3 M	¥ -6 M	-	-	-
Provision of reserve for advanced depreciation of noncurrent assets				-	¥ -702 M
Reversal of reserve for advanced depreciation of noncurrent assets	¥ 45 M	¥ 45 M	¥ 45 M	¥ 45 M	¥ 45 M
Provision of general reserve	¥ -17 B	¥ -17 B	¥ -12 B	¥ -13 B	-
Total changes of items during the period	¥ 2 B	¥ -4 B	¥ 1 B	¥ -332 M	¥ 14 B
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 26 B	¥ 22 B
Disposal of treasury stock	¥ -3 M	¥ -6 M	-	-	-
Provision of reserve for advanced depreciation of noncurrent assets				-	-
Reversal of reserve for advanced depreciation of noncurrent assets					-
Provision of general reserve					-
Total changes of items during the period	¥ 19 B	¥ 12 B	¥ 13 B	¥ 12 B	¥ 14 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M
Disposal of treasury stock	¥ 25 M	¥ 22 M			-
Total changes of items during the period	¥ -77 M	¥ -85 M	¥ -3 M	¥ -1 M	¥ -1 M
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 26 B	¥ 22 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M
Disposal of treasury stock	¥ 20 M	¥ 16 M			-
Total changes of items during the period	¥ 18 B	¥ 12 B	¥ 13 B	¥ 12 B	¥ 14 B
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B
Total changes of items during the period	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B
Total changes of items during the period	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B
Dividends from surplus	¥ -6 B	¥ -7 B	¥ -7 B	¥ -7 B	¥ -7 B
Net income	¥ 25 B	¥ 19 B	¥ 20 B	¥ 26 B	¥ 22 B
Purchase of treasury stock	¥ -103 M	¥ -108 M	¥ -3 M	¥ -2 M	¥ -1 M
Disposal of treasury stock	¥ 20 M	¥ 16 M			-
Net changes of items other than shareholders' equity	¥ -6 B	¥ -6 B	¥ 2 B	¥ -2 B	¥ 2 B
Total changes of items during the period	¥ 12 B	¥ 6 B	¥ 16 B	¥ 9 B	¥ 17 B
Reversal of reserve for special depreciation		¥ -36 M	¥ -21 M
Total changes of items during the period	¥ -54 M	¥ -36 M	¥ -21 M
Reversal of reserve for special depreciation	¥ 54 M	¥ 36 M	¥ 21 M
Reversal of reserve for special depreciation
Disposal of treasury stock	¥ -1 M
Total changes of items during the period	¥ -1 M
Disposal of treasury stock	¥ -1 M
Reversal of reserve for advanced depreciation of noncurrent assets	¥ -45 M	¥ -45 M
Reversal of reserve for special depreciation	¥ -54 M	¥ -36 M

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: Dainippon Sumitomo Pharma (Annual )

Statement Type

Annual : Dainippon Sumitomo Pharma

First quarter : Dainippon Sumitomo Pharma

Second quarter : Dainippon Sumitomo Pharma

Third quarter : Dainippon Sumitomo Pharma

Analysis Menu

Outline : Dainippon Sumitomo Pharma

Statement : Dainippon Sumitomo Pharma

Rating : Dainippon Sumitomo Pharma

Indicator : Dainippon Sumitomo Pharma

Download : Dainippon Sumitomo Pharma

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Osaka - EDIUNET Prefectures

Osaka大阪市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
Dainippon Sumitomo Pharma	4506	TSE 1st	Chemicals	3	Annual	A

Related Company

小林製薬 (Sales ¥ 121 B)

Kao (Sales ¥ 1.0 T)

KUMIAI CHEMICAL INDUSTRY (Sales ¥ 49 B)

Sekisui Chemical (Sales ¥ 1.0 T)

SAKATA INX (Sales ¥ 123 B)

TAKASAGO INTERNATIONAL (Sales ¥ 118 B)

長谷川香料 (Sales ¥ 45 B)

TOWA PHARMACEUTICAL (Sales ¥ 55 B)

Aica Kogyo (Sales ¥ 101 B)

Noevir Holdings (Sales ¥ 46 B)

東京応化工業 (Sales ¥ 72 B)

TOAGOSEI CO (Sales ¥ 148 B)

Nichi-Iko Pharmaceutical (Sales ¥ 93 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .